Author Archives: Joana Fernandes, PhD

LAMA Therapies Carry Lesser Risk of Flares and Side Effects Than LABA in People with Stable COPD, Study Says

LAMA (long-acting muscarinic antagonist) treatments may be more beneficial to people with stable chronic obstructive pulmonary disease (COPD) than those with LABA (long-acting beta2-agonist), especially in patients at risk of frequent exacerbations, according to results of a recent review study. Both LAMA and LABA are long-lasting bronchodilators, widely used as first-line treatments…

Aerobika Device Shows Promise as Treatment for Bronchiectasis as Well as COPD

The Aerobika device, which Monaghan Medical Corporation (MMC) developed to ease symptoms of chronic obstructive pulmonary disease (COPD), may also be effective in patients with non-cystic fibrosis (CF) bronchiectasis, according to a study. The research, “Non-Cystic Fibrosis Bronchiectasis: Regional Abnormalities And Response To Airway Clearance Therapy Using Pulmonary Functional…

Sugar Molecule, Keratan Sulfate, May Protect Lungs Against COPD

A sugar molecule called keratan sulfate could play a protective role against inflammation and emphysema associated with chronic obstructive pulmonary disease (COPD), according to a new study. The study, “A Keratan Sulfate Disaccharide Prevents Inflammation And The Progression Of Emphysema In Murine Models,” was published in the American…